P

Inventor

NARGUND RAVI

US36 patents
⚠️ This page may combine multiple inventors who share the name “NARGUND RAVI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK SHARP & DOHME

16 patents
US9364482B2Jun 14, 2016

Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases

MERCK SHARP & DOHME8 citations84
US10183981B2Jan 22, 2019

Insulin receptor partial agonists

MERCK SHARP & DOHME5 citations83
US9243002B2Jan 26, 2016

Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C

MERCK SHARP & DOHME8 citations83
US10793615B2Oct 6, 2020

Long-acting co-agonists of the glucagon and GLP-1 receptors

MERCK SHARP & DOHME4 citations72
US10413593B2Sep 17, 2019

Co-agonists of the glucagon and GLP-1 receptors

MERCK SHARP & DOHME2 citations72
US10017556B2Jul 10, 2018

Insulin receptor partial agonists

MERCK SHARP & DOHME3 citations72
US11041009B2Jun 22, 2021

Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes

MERCK SHARP & DOHME2 citations71
US9932311B2Apr 3, 2018

Antidiabetic tricyclic compounds

MERCK SHARP & DOHME4 citations71
US11492385B2Nov 8, 2022

Long-acting co-agonists of the glucagon and GLP-1 receptors

MERCK SHARP & DOHME1 citations61
US10689430B2Jun 23, 2020

Insulin receptor partial agonists

MERCK SHARP & DOHME1 citations61
US11058775B2Jul 13, 2021

Insulin dimer-incretin conjugates

MERCK SHARP & DOHME0 citations52
US11034661B2Jun 15, 2021

Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors

MERCK SHARP & DOHME0 citations51
US10800827B2Oct 13, 2020

Insulin receptor partial agonists

MERCK SHARP & DOHME0 citations51
US8354394B2Jan 15, 2013

Diuretics

MERCK SHARP & DOHME0 citations51
US9809568B2Nov 7, 2017

Compounds inhibiting leucine-rich repeat kinase enzyme activity

MERCK SHARP & DOHME1 citations50
US9493461B2Nov 15, 2016

Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C

MERCK SHARP & DOHME0 citations40

MERCK & CO INC

15 patents
US5721251AFeb 24, 1998

Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone

MERCK & CO INC75 citations95
US5767118AJun 16, 1998

4-Heterocyclic peperidines promote release of growth hormone

MERCK & CO INC36 citations93
US5656606AAug 12, 1997

Camphor compounds promote release of growth hormone

MERCK & CO INC30 citations93
US6121325ASep 19, 2000

Naphthyl compounds promote release of growth hormone

MERCK & CO INC33 citations92
US6063796AMay 16, 2000

Somatostatin agonists

MERCK & CO INC38 citations92
US5965565AOct 12, 1999

Piperidines promote release of growth hormone

MERCK & CO INC30 citations92
US5880125AMar 9, 1999

4-spiroindoline piperidines promote release of growth hormone

MERCK & CO INC35 citations92
US5804578ASep 8, 1998

Piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone

MERCK & CO INC57 citations92
US5663171ASep 2, 1997

Acyclic compounds promote release of growth hormone

MERCK & CO INC45 citations92
US5559128ASep 24, 1996

3-substituted piperidines promote release of growth hormone

MERCK & CO INC51 citations92
US5492920AFeb 20, 1996

Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone

MERCK & CO INC53 citations92
US5877182AMar 2, 1999

Piperidines promote release of growth hormone

MERCK & CO INC49 citations91
US5925659AJul 20, 1999

Antibacterial agents

MERCK & CO INC38 citations90
US5830433ANov 3, 1998

Radiolabeled growth hormone secretagogue

MERCK & CO INC26 citations89
US5777112AJul 7, 1998

Piperazine compounds promote release of growth hormone

MERCK & CO INC13 citations68

HE SHUWEN

2 patents

MCCOMAS CASEY C

1 patent

ALI AMJAD

1 patent

JANSSEN PHARMACEUTICA NV

1 patent